PL
NVO

Parkwood LLC’s Novo Nordisk NVO Stock Holding History

Parkwood LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-159,438
Closed -$11M – 97
2025
Q2 		$11M Sell
159,438
-303,133
-66% -$20.6M 0.99% 38
2025
Q1 		$32.1M Buy
462,571
+200,976
+77% +$16.6M 2.96% 3
2024
Q4 		$22.5M Sell
261,595
-2,385
-0.9% -$258K 2.56% 4
2024
Q3 		$31.4M Buy
263,980
+27,941
+12% +$3.73M 2.21% 6
2024
Q2 		$33.7M Buy
236,039
+61,245
+35% +$8.12M 4.19% 2
2024
Q1 		$22.4M Buy
174,794
+27,966
+19% +$3.33M 2.02% 6
2023
Q4 		$15.2M Sell
146,828
-22,186
-13% -$2.19M 1.81% 15
2023
Q3 		$15.4M Buy
169,014
+17,876
+12% +$1.57M 1.67% 8
2023
Q2 		$12.2M Sell
151,138
-47,634
-24% -$3.89M 2.23% 9
2023
Q1 		$15.8M Buy
198,772
+122,860
+162% +$8.71M 2.17% 8
2022
Q4 		$5.14M Buy
+75,912
New +$4.45M 0.78% 34
2022
Q3 		– Sell
-70,778
Closed -$3.94M – 171
2022
Q2 		$3.94M Sell
70,778
-114,952
-62% -$6.38M 0.7% 47
2022
Q1 		$10.3M Buy
185,730
+47,582
+34% +$2.44M 1.69% 12
2021
Q4 		$7.74M Sell
138,148
-2,490
-2% -$135K 1.32% 20
2021
Q3 		$6.75M Sell
140,638
-39,170
-22% -$1.89M 0.82% 29
2021
Q2 		$7.53M Sell
179,808
-1,904
-1% -$73.8K 0.87% 24
2021
Q1 		$6.13M Buy
181,712
+17,654
+11% +$629K 1.08% 28
2020
Q4 		$5.73M Sell
164,058
-22,996
-12% -$795K 0.69% 43
2020
Q3 		$6.49M Buy
187,054
+44,540
+31% +$1.48M 1% 29
2020
Q2 		$4.67M Buy
+142,514
New +$4.55M 0.84% 39

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Parkwood LLC's NVO Position: Q3 2025 in Review

Parkwood LLC sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 159,438 shares — an estimated $11M sold.

Parkwood LLC first reported a position in NVO in Q2 2020 and held it in 20 quarters. The position peaked at $33.7M in Q2 2024. 1,398 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Parkwood LLC reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Parkwood LLC sold 159,438 Novo Nordisk shares in Q3 2025, an estimated $11M.
  • Parkwood LLC first reported a position in Novo Nordisk in Q2 2020 and held it in 20 quarters.
  • Parkwood LLC's Novo Nordisk position peaked at $33.7M in Q2 2024.
  • 1,398 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Parkwood LLC's 13F filing for Q3 2025, filed 14 Nov 2025.